Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Metjian · SciRah

Researcher profile · Semantic Scholar

A. Metjian

Share profile

A. Metjian — researcher profile on SciRah

h-index: 15
Works: 68
Citations: 1,725

Most-cited papers

Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura
M. Scully, S. Cataland, F. Peyvandi, P. Coppo +9 more
2019New England Journal of Medicine791 citations Open access
Semantic Scholar
Cytoskeletal Reorganization by G Protein-Coupled Receptors Is Dependent on Phosphoinositide 3-Kinase γ, a Rac Guanosine Exchange Factor, and Rac
A. Ma, A. Metjian, S. Bagrodia, Stephen Taylor +1 more
1998Molecular and Cellular Biology200 citations Open access
Semantic Scholar
Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: integrated analysis.
F. Peyvandi, S. Cataland, M. Scully, P. Coppo +8 more
2021Blood Advances70 citations Open access
Semantic Scholar
Agonists Cause Nuclear Translocation of Phosphatidylinositol 3-Kinase γ
A. Metjian, Richard L. Roll, A. Ma, C. Abrams
1999Journal of Biological Chemistry67 citations Open access
Semantic Scholar
Efficacy and safety of open‐label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study
P. Knoebl, S. Cataland, F. Peyvandi, P. Coppo +8 more
2019Journal of Thrombosis and Haemostasis58 citations Open access
Semantic Scholar
Validation of the high-dose heparin confirmatory step for the diagnosis of heparin-induced thrombocytopenia.
Nicole L. Whitlatch, David F. Kong, A. Metjian, G. Arepally +1 more
2010Blood54 citations Open access
Semantic Scholar
Acquired, non‐amyloid related factor X deficiency: review of the literature
Grace M. Lee, Wei Duan-Porter, A. Metjian
2012Haemophilia42 citations
Semantic Scholar
Race, Rituximab, and Relapse in TTP.
S. Chaturvedi, A. Antun, A. Farland, R. Woods +25 more
2022Blood40 citations Open access
Semantic Scholar
Adjuvant low-dose rituximab and plasma exchange for acquired TTP.
J. Zwicker, Joshua Muia, L. Dolatshahi, Lisa A. Westfield +6 more
2019Blood39 citations Open access
Semantic Scholar
Novel Use of a Thrombopoietin Mimetic for Chronic Immune Thrombocytopenic Purpura in Pregnancy
A. Patil, S. Dotters-Katz, A. Metjian, A. James +1 more
2013Obstetrics and Gynecology39 citations Open access
Semantic Scholar
Caplacizumab in adult patients with acquired thrombotic thrombocytopenic purpura
Ashley Hanlon, A. Metjian
2020Therapeutic Advances in Hematology36 citations Open access
Semantic Scholar
Bleeding symptoms and laboratory correlation in patients with severe von Willebrand disease
A. Metjian, C. Wang, S. Sood, A. Cuker +3 more
2009Haemophilia34 citations
Semantic Scholar
Long‐term follow‐up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post‐HERCULES study
M. Scully, J. de la Rubia, K. Pavenski, A. Metjian +10 more
2022Journal of Thrombosis and Haemostasis32 citations Open access
Semantic Scholar
ASH evidence-based guidelines: should asymptomatic patients with antiphospholipid antibodies receive primary prophylaxis to prevent thrombosis?
A. Metjian, W. Lim
2009Hematology. American Society of Hematology. Education Program32 citations
Semantic Scholar
Results of the Randomized, Double-Blind, Placebo-Controlled, Phase 3 Hercules Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura
M. Scully, S. Cataland, F. Peyvandi, P. Coppo +9 more
201719 citations
Semantic Scholar
Similarity in Joint Function Limitation in Type 3 Von Willebrand Disease and Moderate Haemophilia A
S. Sood, A. Cuker, C. Wang, A. Metjian +3 more
2013Haemophilia14 citations Open access
Semantic Scholar
Ex vivo assays to detect complement activation in complementopathies
Xuan Yuan, Jia Yu, G. Gerber, S. Chaturvedi +6 more
2020Clinical Immunology13 citations Open access
Semantic Scholar
HLA sensitization in solid organ transplantation: a primer on terminology, testing, and clinical significance for the apheresis practitioner
S. Abbes, A. Metjian, A. Gray, T. Martinu +5 more
2017Therapeutic apheresis and dialysis13 citations Open access
Semantic Scholar
The thrombotic microangiopathy Registry of North America: A United States multi‐institutional TMA network
A. Metjian, Y. Tanhehco, Nicole A. Aqui, Vijay G. Bhoj +5 more
2016Journal of clinical apheresis10 citations
Semantic Scholar
A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP Registry
Mouhamed Yazan Abou-Ismail, Chong Zhang, A. Presson, S. Chaturvedi +27 more
2023Blood Advances9 citations Open access
Semantic Scholar
Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Dovepress New Advances in the Treatment of Adult Chronic Immune Thrombocytopenic Purpura: Role of Thrombopoietin Receptor-stimulating Agents
A. Metjian, C. Abrams
9 citations
Semantic Scholar
Early Results of Phase II Study Using OMS721 in Patients with Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (HCT-TMA)
S. Khaled, Yok-Lam Kwong, Mark Smith, A. Metjian +1 more
20178 citations Open access
Semantic Scholar
A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpura
Mouhamed Yazan Abou-Ismail, Chong Zhang, A. Presson, S. Chaturvedi +27 more
2024Research and Practice in Thrombosis and Haemostasis7 citations Open access
Semantic Scholar
Safety and tolerability of solvent/detergent‐treated plasma for pediatric patients requiring therapeutic plasma exchange: An open‐label, multicenter, postmarketing study
C. Josephson, S. Goldstein, D. Askenazi, C. Cohn +4 more
2021Transfusion7 citations Open access
Semantic Scholar
Integrated Efficacy Results from the Phase II and Phase III Studies with Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura
F. Peyvandi, S. Cataland, M. Scully, P. Coppo +8 more
2018Blood7 citations
Semantic Scholar
Proteomics of arterial thrombi in acute limb ischemia
Robert D Stegman, Lauren R. Schmitt, K. Hansen, Adrianna Kayden +3 more
2025Journal of Thrombosis and Thrombolysis5 citations
Semantic Scholar
A rare CALR variant mutation and a review of CALR in essential thrombocythemia
R. Diep, A. Metjian
2018Journal of Thrombosis and Thrombolysis5 citations
Semantic Scholar
Waldenström Macroglobulinemia in Hepatitis C: Case Report and Review of the Current Literature
R. Nipp, Aaron Mitchell, Allyson M. Pishko, A. Metjian
2014Case Reports in Oncological Medicine5 citations Open access
Semantic Scholar
Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab era
Ayotola A Fatola, Michael D Evans, Jenna Brown, Elisabeth Davis +28 more
2024Blood Advances4 citations
Semantic Scholar
C5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy
Hridaya Shah, Hang Chen, Xiang-Zuo Pan, A. Metjian +3 more
2022Blood Advances4 citations Open access
Semantic Scholar
Differential Effect of Rituximab on Relapse-Free Survival in De Novo and Relapsed Immune Thrombotic Thrombocytopenic Purpura in African-American and Caucasian Populations
Mazepa Marshall, Michael R. Evans, Elizabeth E. Davis, Andrew D. Johnson +26 more
2019Blood4 citations Open access
Semantic Scholar
African American Race Is Associated with Decreased Relapse-Free Survival in Immune Thrombotic Thrombocytopenic Purpura
Angela Liu, M. Mazepa, Elizabeth E. Davis, Andrew D. Johnson +26 more
2019Blood4 citations Open access
Semantic Scholar
Risk Factors and Manageability of the Mainly Mild Mucocutaneous Bleeding Profile Observed in Attp Patients Treated with Caplacizumab during the Phase III Hercules Study
S. Cataland, M. Scully, F. Peyvandi, P. Coppo +9 more
2018Blood4 citations Open access
Semantic Scholar
Efficacy of Adjuvant Low Dose Rituximab and Plasma Exchange for Acquired TTP with Severe ADAMTS13 Deficiency — Results of the ART Study
J. Sadler, Joshua Muia, L. Dolatshahi, Lisa A. Westfield +5 more
2018Blood4 citations Open access
Semantic Scholar
Safety of Caplacizumab for the Treatment of Patients with Acquired Thrombotic Thrombocytopenic Purpura - Results Normalized to Time of Exposure in a Double-Blind, Placebo-Controlled, Phase 3 Hercules Study
J. Kremer Hovinga, M. Scully, S. Cataland, F. Peyvandi +9 more
2018Blood4 citations
Semantic Scholar
Integrated Safety Results from the Phase II and Phase III Studies with Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura
P. Knöbl, M. Scully, S. Cataland, F. Peyvandi +8 more
2018Blood4 citations
Semantic Scholar
INDICATIONS FOR AND OUTCOMES OF THERAPEUTIC PLASMA EXCHANGE AFTER CARDIAC TRANSPLANTATION: A SINGLE CENTER RETROSPECTIVE STUDY
Oluwatoyosi A. Onwuemene, S. Grambow, C. Patel, R. Mentz +5 more
2018Journal of clinical apheresis4 citations Open access
Semantic Scholar
Efficacy of Caplacizumab in Patients with aTTP in the HERCULES Study According to Baseline Disease Severity
P. Coppo, S. Cataland, F. Peyvandi, P. Knoebl +8 more
2019Blood3 citations Open access
Semantic Scholar
Novel therapeutic approaches for thrombotic thrombocytopenic purpura
Y. Tanhehco, G. Arepally, A. Metjian
2017Current opinion in hematology3 citations
Semantic Scholar
The Thrombotic Microangiopathy Registry of North America
A. Metjian, Y. Tanhehco, H. Pham, Nicole A. Aqui +4 more
20153 citations
Semantic Scholar
New insights and therapeutics for immune-mediated thrombocytopenia
A. Metjian, C. Abrams
2008Expert Review of Cardiovascular Therapy3 citations
Semantic Scholar
Real‐world safety and effectiveness of recombinant porcine sequence factor VIII in acquired haemophilia A: A non‐interventional, post‐authorization safety study
M. Tarantino, Brandon M. Hardesty, A. Metjian, T. Ortel +7 more
2023Haemophilia2 citations Open access
Semantic Scholar
Safety Results Normalized to Time of Exposure during the Phase 3 HERCULES Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura
J. Kremer, M. Scully, S. Cataland, F. Peyvandi +9 more
2019Hämostaseologie2 citations
Semantic Scholar
Efficacy of Caplacizumab in Patients with aTTP in the HERCULES Study According to Initial Immunosuppression Regimen
K. Pavenski, P. Knoebl, M. Scully, J. Kremer Hovinga +8 more
2019Blood2 citations Open access
Semantic Scholar
rVWF: treatment finally reaches the modern age.
A. Metjian
2015Blood2 citations
Semantic Scholar
New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents
A. Metjian, Charles S. Abrams
20092 citations
Semantic Scholar
iTTP: more long-term consequences.
A. Metjian
2023Blood1 citations Open access
Semantic Scholar
The Role of ADAMTS13 Activity Levels on Disease Exacerbation or Relapse in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura: Post Hoc Analysis of the Phase 3 HERCULES and Post-HERCULES Studies
Johanna A. Kremer Hovinga Strebel, J. de la Rubia, K. Pavenski, A. Metjian +9 more
2022Blood1 citations Open access
Semantic Scholar
Long-Term Safety and Efficacy of Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura (aTTP): The Post-HERCULES Study
M. Scully, J. de la Rubia, K. Pavenski, A. Metjian +10 more
2021Blood1 citations Open access
Semantic Scholar
Narratives of Patients with Fatal Outcomes During the Phase 2 TITAN and Phase 3 HERCULES Studies
S. Cataland, M. Scully, F. Peyvandi, P. Knoebl +7 more
2019Blood1 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Cataland×20
Invite
S. Cataland — researcher profile on SciRah
P. Coppo×15
Invite
P. Coppo — researcher profile on SciRah
K. Pavenski×15
Invite
K. Pavenski — researcher profile on SciRah
F. Peyvandi×14
Invite
F. Peyvandi — researcher profile on SciRah

×14

Invite

J. de la Rubia — researcher profile on SciRah

F. Callewaert×14

Invite

F. Callewaert — researcher profile on SciRah

Invite

M. Scully — researcher profile on SciRah

H. De Winter×12

Invite

H. De Winter — researcher profile on SciRah

J. Kremer Hovinga×11

Invite

J. Kremer Hovinga — researcher profile on SciRah

Invite

P. Knoebl — researcher profile on SciRah

S. Chaturvedi×8

Invite

S. Chaturvedi — researcher profile on SciRah

Invite

A. Antun — researcher profile on SciRah